Lung cancer subtyping, particularly differentiating adenocarcinoma (ADC) from squamous
cell carcinoma (SCC), is paramount for clinicians to develop effective treatment strategies. In …

Introduction Lung cancer is a serious global health concern, and its subtypes are closely
linked to lifestyle and dietary habits. Recent research has suggested that malnutrition, over …

Simple Summary The impact of smoking on the development of lung cancer is widely
acknowledged; however, all of the molecular processes behind this effect, as well as their …

Simple Summary Ablative radiotherapy for central early stage non-small cell lung cancer
(NSCLC) is controversial in its feasibility and optimal dose prescription due to the risk of …

Background: Non-small-cell lung cancer (NSCLC) with additional nodule (s) located in the
same lobe or ipsilateral different lobe were designated as T3 and T4, respectively, which …

The aim of this study was to explore potential novel plasma protein biomarkers for lung
adenocarcinoma (LUAD). A plasma proteomics analysis was carried out and candidate …

Simple Summary Lung cancer, including non-small-cell lung cancer (NSCLC), is one of the
leading causes of cancer-related deaths worldwide. NSCLC treatment has undergone a …

Lung cancer is a highly heterogeneous disease. Cancer cells and other cells within the
tumor microenvironment interact to determine disease progression, as well as response to …

This study tackles the pressing challenge of lung cancer detection, the foremost cause of
cancer-related mortality worldwide, hindered by late detection and diagnostic limitations …

Background The roles and clinical values of synaptojanin 2 (SYNJ2) in lung squamous cell
carcinoma (LUSC) remain unclear. Methods A total of 2824 samples from multi-center were …